Mandate

Vinge advises Borgo in connection with the establishment of its MTN and covered bond programme and its inaugural issuance of MTNs

February 03, 2022 Banking and Finance

Vinge has advised Borgo AB (publ) (“Borgo”) in connection with the establishment of its SEK 50 billion MTN and covered bond programme (the “Programme”) and its inaugural issuance of SEK 1,75 billion MTNs (the “MTNs”).

The covered bonds issued under the Programme will be secured by underlying Swedish mortgage loans in accordance with the Swedish Covered Bonds Act. The MTNs carry an interest rate of STIBOR 3M + 0,90% and are intended to be listed on the corporate bond list of Nasdaq Stockholm. The Programme also caters for future issuances of green medium term notes, at the discretion of Borgo.

Borgo is a new independent mortgage lending company co-owned by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken. Additional investors and Sparbanken Syd have committed to invest in Borgo. Borgo focuses on financing and offering mortgages to Swedish consumers.

Vinge’s team mainly consisted of Mikael Ståhl, Lionardo Ojeda, Axel Jansson and Felix Möller.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026